Pragmativ clinical trial in trauma: crash 2 trial in Perú
DOI:
https://doi.org/10.17843/rpmesp.2008.251.1247Keywords:
Antifibrynolitics, Tranexamic acid, Clinical trial, Traffic accidentsAbstract
CRASH-2 is a pragmatic clinical trial which evaluates the efficacy of a widely available, low cost antifibrinolytic for the prevention of mortality and bleeding in patients with trauma. In this article we present some issues related to the magnitude of the problem as well as the need for research in trauma relevant to the Peruvian context. The rationale for the CRASH-2 trial and the Peruvian experience up to date are also discusse.Downloads
Download data is not yet available.
Downloads
Published
2008-03-31
Issue
Section
Symposium
How to Cite
1.
Soto A, Torres E, Caballero J, Azabache-Puente W, Malca-Polo CE, Gonzáles-Portillo M, et al. Pragmativ clinical trial in trauma: crash 2 trial in Perú. Rev Peru Med Exp Salud Publica [Internet]. 2008 Mar. 31 [cited 2024 Nov. 4];25(1). Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/1247